Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry of Treatment Outcomes in a Non-study Population of Symptomatic Metastasized Castration Resistant Prostate Cancer (mCRPC) Patients Treated With Radium-223

NCT03223597 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT03223597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03223597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry of Treatment Outcomes in a Non-study Population of Symptomatic Metastasized Castration Resistant Prostate Cancer (mCRPC) Patients Treated With Radium-223
Lead sponsor
The Netherlands Cancer Institute
Phase
Observational
Overall status
Completed
Start date
January 17, 2015
Completion date
March 1, 2018
Enrollment
300 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, prostate cancer metastatic